デフォルト表紙
市場調査レポート
商品コード
1439563

血管パッチの世界市場:洞察、競合情勢、市場予測:2030年

Vascular Patches - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.87円
血管パッチの世界市場:洞察、競合情勢、市場予測:2030年
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血管パッチの市場規模は、2024年から2030年までの予測期間中に7.37%のCAGRで拡大すると予測されています。血管パッチの需要増加は、遺伝的要因、加齢、肥満、不健康で座りがちなライフスタイルによる心血管疾患の有病率の増加、悪い食習慣、血管疾患になりやすい高齢者患者の増加、手術における血管パッチの使用増加などが主な要因である、低侵襲手術(MIS)の需要増加、血管細胞再生、細胞統合、組織リモデリングなどの技術進歩が世界的に市場を強化し、2024年~2030年の予測期間中に血管パッチ市場の成長に寄与すると予測されています。

血管パッチ市場は、様々な理由により製品需要が伸びています。加齢、肥満、不健康で座りがちなライフスタイル、タバコやアルコールの消費、食生活の乱れなどの様々な要因による虚血性心疾患や脳卒中などの心血管疾患(CVD)の世界の有病率の増加、心血管疾患になりやすい高齢者患者の増加、低侵襲手術の需要の高まり、世界中の様々な政府の取り組みなどが市場を強化すると予想されています。

世界保健機関(WHO)の2022年によると、2019年には世界全体で推定1,790万人がCVDで死亡し、このうち85%が心臓発作と脳卒中によるものでした。同出典によると、CVDによる世界の死亡の少なくとも4分の3は低・中所得国で発生しています。死亡率は、タバコの使用、不健康な食事、肥満、運動不足、アルコールの有害な使用などの危険因子を予防し、障害を治療することによって減少させることができます。心臓血管疾患は外科手術によって治療されることが多く、その際、医師は正確な閉鎖を確保するために血管パッチを使用します。パッチは縫合穴からの出血を減らすのに役立ちます。心血管疾患の有病率は世界的に増加しており、その結果、心血管手術の数が増加し、予測期間における血管パッチ市場をさらに促進しています。

当レポートでは、世界の血管パッチ市場について調査し、市場の概要とともに、素材タイプ別、応用タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 血管パッチ市場レポートのイントロダクション

第2章 血管パッチ市場のエグゼクティブサマリー

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 血管パッチ市場の主な要因分析

  • 血管パッチ市場の促進要因
  • 血管パッチ市場の抑制要因と課題
  • 血管パッチ市場の機会

第5章 血管パッチ市場におけるポーターのファイブフォース分析

第6章 血管パッチ市場に対するCOVID-19の影響分析

第7章 血管パッチ市場の概要

  • 素材タイプ別
  • 応用タイプ別
  • エンドユーザー別
  • 地域別

第8章 血管パッチ市場の世界企業シェア分析-主要3~5社

第9章 血管パッチ市場の企業と製品プロファイル

  • B. Braun Melsungen AG
  • Baxter.
  • Getinge AB
  • Terumo Corporation
  • Edwards Lifesciences Corporation.
  • LeMaitre
  • W. L. Gore & Associates, Inc.
  • CryoLife, Inc.
  • Aziyo
  • Medtrade Products Ltd
  • Collagen Solutions Plc
  • FOC Medical S.A.
  • Obex
  • Anteris
  • Medtronic
  • Labcor Laboratorios
  • BD.
  • Johnson & Johnson Services, Inc.
  • Neovasc Inc.
  • Axio Biosolutions

第10章 KOL の見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Vascular patches Market in Global (2021-2030)
  • Table 4: Vascular patches Market in Global by Material Type (2021-2030)
  • Table 5: Vascular patches Market in Global by Application Type (2021-2030)
  • Table 6: Vascular patches Market in Global by End User (2021-2030)
  • Table 7: Vascular patches Market in Global by Geography (2021-2030)
  • Table 8: Vascular patches Market in North America (2021-2030)
  • Table 9: Vascular patches Market in North America by Country (2021-2030)
  • Table 10: Vascular patches Market in the US (2021-2030)
  • Table 11: Vascular patches Market in Canada (2021-2030)
  • Table 12: Vascular patches Market in Mexico (2021-2030)
  • Table 13: Vascular patches Market in Europe (2021-2030)
  • Table 14: Vascular patches Market in Europe by Country (2021-2030)
  • Table 15: Vascular patches Market in France (2021-2030)
  • Table 16: Vascular patches Market in Germany (2021-2030)
  • Table 17: Vascular patches Market in the United Kingdom (2021-2030)
  • Table 18: Vascular patches Market in Italy (2021-2030)
  • Table 19: Vascular patches Market in Spain (2021-2030)
  • Table 20: Vascular patches Market in Russia (2021-2030)
  • Table 21: Vascular patches Market in Rest of Europe (2021-2030)
  • Table 22: Vascular patches Market in APAC (2021-2030)
  • Table 23: Vascular patches Market in APAC by Country (2021-2030)
  • Table 24: Vascular patches Market in China (2021-2030)
  • Table 25: Vascular patches Market in Japan (2021-2030)
  • Table 26: Vascular patches Market in India (2021-2030)
  • Table 27: Vascular patches Market in Australia (2021-2030)
  • Table 28: Vascular patches Market in South Korea (2021-2030)
  • Table 29: Vascular patches Market in Rest of APAC (2021-2030)
  • Table 30: Vascular patches Market in Rest of World (2021-2030)
  • Table 31: Vascular patches Market in RoW by Region (2021-2030)
  • Table 32: Vascular patches Market in Middle East (2021-2030)
  • Table 33: Vascular patches Market in Africa (2021-2030)
  • Table 34: Vascular patches Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Vascular patches Market in Global (2021-2030)
  • Figure 4: Vascular patches Market in Global by Material Type (2021-2030)
  • Figure 5: Vascular patches Market in Global by Application Type (2021-2030)
  • Figure 6: Vascular patches Market in Global by End User (2021-2030)
  • Figure 7: Vascular patches Market in Global by Geography (2021-2030)
  • Figure 8: Vascular patches Market in North America (2021-2030)
  • Figure 9: Vascular patches Market in North America by Country (2021-2030)
  • Figure 10: Vascular patches Market in the US (2021-2030)
  • Figure 11: Vascular patches Market in Canada (2021-2030)
  • Figure 12: Vascular patches Market in Mexico (2021-2030)
  • Figure 13: Vascular patches Market in Europe (2021-2030)
  • Figure 14: Vascular patches Market in Europe by Country (2021-2030)
  • Figure 15: Vascular patches Market in France (2021-2030)
  • Figure 16: Vascular patches Market in Germany (2021-2030)
  • Figure 17: Vascular patches Market in the United Kingdom (2021-2030)
  • Figure 18: Vascular patches Market in Italy (2021-2030)
  • Figure 19: Vascular patches Market in Spain (2021-2030)
  • Figure 20: Vascular patches Market in Russia (2021-2030)
  • Figure 21: Vascular patches Market in Rest of Europe (2021-2030)
  • Figure 22: Vascular patches Market in APAC (2021-2030)
  • Figure 23: Vascular patches Market in APAC by Country (2021-2030)
  • Figure 24: Vascular patches Market in China (2021-2030)
  • Figure 25: Vascular patches Market in Japan (2021-2030)
  • Figure 26: Vascular patches Market in India (2021-2030)
  • Figure 27: Vascular patches Market in Australia (2021-2030)
  • Figure 28: Vascular patches Market in South Korea (2021-2030)
  • Figure 29: Vascular patches Market in Rest of APAC (2021-2030)
  • Figure 30: Vascular patches Market in Rest of World (2021-2030)
  • Figure 31: Vascular patches Market in RoW by Region (2021-2030)
  • Figure 32: Vascular patches Market in Middle East (2021-2030)
  • Figure 33: Vascular patches Market in Africa (2021-2030)
  • Figure 34: Vascular patches Market in South America (2021-2030)
  • Figure 35: Market Drivers
  • Figure 36: Market Barriers
  • Figure 37: Marker Opportunities
  • Figure 38: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0390

Vascular Patches Market By Material Type (Biologic Vascular Patches And Synthetic Vascular Patches), By Application Type (Carotid Endarterectomy, Aortic Aneurysms, Profundaplasty, And Other), By End-User (Hospital, Ambulatory Surgical Centers, And Other), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rise in prevalence of cardiovascular diseases such as ischemic heart diseases and stroke due to unhealthy lifestyles and bad eating habits and increasing number of geriatric population prone to vascular disease

Global vascular patches market is estimated to grow at a CAGR of 7.37% during the forecast period from 2024 to 2030. The increase in demand for vascular patches is primarily attributed to the increase in the prevalence of cardiovascular diseases due to genetic factor, age, obesity, and unhealthy and sedentary lifestyles, bad eating habits and increasing number of geriatric patients prone to vascular diseases, increasing use of vascular patches in surgeries, increased demand of minimally invasive surgeries (MIS), and technological advancements like vascular cell regeneration, cellular integration, and tissue remodeling across the world are anticipated to bolster the market, thereby contributing to the growth of the vascular patches market during the forecast period from 2024-2030.

Vascular Patches Market Dynamics:

The vascular patches market is witnessing a growth in product demand owing to various reasons. The increased prevalence of cardiovascular disease (CVDs) such as, ischemic heart disease and stroke worldwide due to various factors such as, age, obesity, unhealthy and sedentary lifestyles, consumption of tobacco and alcohol and poor diet, increasing number of geriatric patients prone to cardiovascular diseases, rising demand of minimally invasive surgeries, and various government initiatives across the world are anticipated to bolster the market.

According to World Health Organization (WHO) 2022, in 2019, globally an estimation of 17.9 million people died from CVDs, out of these deaths, 85% were due to heart attack and stroke. According to the same source, at least three-quarters of the world's deaths from CVDs occur in low- and middle-income countries. The mortality rate can be decreased by preventing the risk factors such as tobacco use, unhealthy diet and obesity, physical inactivity and harmful use of alcohol and also by treating the disorder. Cardiovascular disease are often treated by surgical procedures in which the physician usually uses vascular patches to ensure precise closures. The patches helps to reduce suture hole bleeding. As the prevalence of cardiovascular disease is increasing globally thereby owing to increase the number of cardiovascular surgeries, further propelling the market of vascular patches in the forecast period.

According to Pan American Health Organization (PAHO) 2022, the burden of cardiovascular diseases in the region of the Americas, 2000-2019, ischemic heart disease is responsible for 73.6 deaths per 100,000 population globally and stroke for 32.3 deaths per 100,000 population globally. As per the same source, ischemic heart disease and stroke are the two major underlying causes of CVD mortality and disability. The prevalence of ischemic heart disease and stroke is continuously rising owing to increase in the number of surgeries for its treatment and thus increasing the demand of vascular patches in the market.

Most cardiovascular diseases can be prevented by addressing behavioral risk factors such as tobacco use, unhealthy diet and obesity, physical inactivity and harmful use of alcohol. According to WHO 2022, tobacco kills up to half of its users. Tobacco kills more than 8 million people globally each year. More than 7 million of those deaths are the result of direct tobacco use while around 1.2 million are the result of non-smokers being exposed to second-hand smoke. Moreover, according to WHO 2020, every year, 1.9 million people die globally from tobacco-induced heart disease. Smoking tobacco raises triglycerides levels and lowers good cholesterol (HDL) levels. Smoking also makes blood sticky and more likely to clot, which can block blood flow to the heart and brain, damaging the cells that line the blood vessels. Moreover, tobacco increases the buildup of plaque (fat, cholesterol, calcium, and other substances) in blood vessels, causing thickening and narrowing of blood vessels. All these changes act as a risk factor for the occurrence of cardiovascular diseases. Thus, as the number of smokers are increasing worldwide, there might be an increase in the prevalence of cardiovascular disorders. Therefore, propelling the demand of vascular patches in the market.

Furthermore, according to World Obesity, it is estimated that 2.7 billion adults will be overweight, over 1 billion affected by obesity, and 177 million adults severely affected by obesity by 2025 globally. Obesity and increased adipose tissue will also influence the pathogenesis of atherosclerosis, increasing the risk of cardiovascular diseases. As the prevalence of obesity is increasing and this may increase the prevalence of cardiovascular ailments owing to an increase in demand of vascular patches in the market.

Australian government in 2019 launched, The Cardiovascular Health Mission that is a $220 million research fund that supports a large program of work to improve heart health and lead to a reduction of stroke patients in Australia. The program aimed to reduce hospitalization, develop clinical trials and new drug therapies, use the unique DNA of a patient to develop new therapies and also looked into why people follow unhealthy lifestyle or have a genetic cause for CVDs.

Moreover, the product launches in local market, in turn, drive the product demand in the market. For instance, in June 2022, Axio Biosolutions announced FDA 510(k) clearance of its hemostatic product Axiostat Patch, which helps to control the moderate to severe bleeding in vascular procedures.

Thus, due to the increasing prevalence of cardiovascular diseases globally and product launches, will pave the way to a rising demand for vascular patches, in turn increasing the vascular patches market growth.

However, product failure or recall, and the limited number of carotid endarterectomy surgeries may pose as a challenge to the vascular patches market growth.

The ongoing COVID-19 pandemic has majorly impacted the market for vascular patches as patients postponed hospital exposure and elective surgeries. Hospital admissions for patients suffering from cardiovascular disorders were not a priority in comparison to the patients suffering from coronavirus. Furthermore, surgeries were temporarily stopped during the pandemic. Most surgeons were doing urgent surgeries. Due to stringent lockdown rules production of some medical devices was shut down. However, patients recovering from coronavirus were at a greater risk of developing cardiovascular diseases. This increased the number of vascular surgeries ultimately increasing the demand of vascular patches amoung the patients, thereby increasing the demand of the device in the market. Moreover, with normalcy and with masses being vaccine, the market is picking up the momentum again as the number of surgeries are increasing again.

Vascular Patches Market Segment Analysis:

Vascular Patches Market by Material Type (Biologic Vascular Patches and Synthetic Vascular Patches), by Application Type (Carotid Endarterectomy, Aortic Aneurysms, Profundaplasty, and Other), by End-User (Hospital, Ambulatory Surgical Centers, and Other), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Material Type segment of the vascular patches market, the biologic vascular patches are estimated to hold a significant share in the vascular patches market during the forecast period (2024-2030). This can be ascribed to the various advantages that are associated with the device.

The most important benefit of biologic vascular patch is that it offers high biocompatibility with the body. Biological grafts are derived from human, bovine, and porcine tissue that has been decellularized to leave a collagen matrix. Therefore, the biomaterials are mostly biocompatible with the body.

Moreover, the structure of bioactive material in the biologic vascular patch acts as a regenerative framework that supports remodeling and new collagen deposition.

The demand for biologic vascular patches is expected to increase during the forecasted period. This is owing to the various properties of the patch like cell migration and differentiation. The bioactive material in the biologic vascular patch serves as a substrate for cell migration and differentiation.

Additionally, biologic vascular patches are often degraded naturally in the body. Biomaterial of biologic vascular patches possess anti-microbial peptides (AMPs), which exposes molecular sites and signaling molecules that influence cell behaviors such as chemotaxis, adhesion, differentiation, and angiogenesis. Thus, the degradation of biologic vascular patch is easy and no toxicity is observed.

Furthermore, the biologic vascular patches reduces the risk of infection after the surgery. The synthetic materials can harbor bacteria and generally must be removed when infected whereas the biologic vascular patches are resistant to bacterial infection because the degradation products often show robust antibacterial activity.

Biologic vascular patches possess an inflammatory profile that promotes healing of the cuts. The inflammatory response signals fibroblasts resulting in new collagen deposition.

The tensile strength of most synthetic materials generally far exceeds the physiologic demand. However, excessive strength can lead to increased inflammation and loss of elasticity. This disadvantage is overpowered by the biological biomaterials used in biologic vascular patches.

Other factor like ideal porosity of biologic vascular patches and the knitted mesh will propel the market of vascular patch in the forecast period.

Moreover, the product launches, in turn, drive the product demand in the market. For instance, in February 2020, LeMaitre Vascular had announced 510(k) clearance for XenoSure Biologic Patch.

Thus, owing to the various advantages of biologic vascular patches as well as product launches, there will be an increase in the demand for biologic vascular patches, which in turn will drive the vascular patches market growth.

North America is expected to dominate the overall Vascular Patches Market:

Among all the regions, North America is expected to account for the significant share in the global vascular patches market. Rise in prevalence of cardiovascular diseases such as ischemic heart diseases and stroke due to unhealthy lifestyles and bad eating habits, increasing number of geriatric population prone to vascular disease and various government initiations will increase the demand for vascular patches in North America, leading to a rise in the overall vascular patches market growth.

For instance, as per the Centers for Disease Control and Prevention (CDC), Heart Disease Facts 2022, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. Coronary heart disease (CAD) is the most common type of heart disease, killing 360,900 people in 2019 in US, about which 18.2 million adults aged 20 and older have Coronary Artery Disease. As per the same source, in the United States, someone has a heart attack every 40 seconds and an estimation was done that every year, about 805,000 people in the United States have a heart attack. Above statistics concludes that the prevalence of CVDs like CAD and heart attack are increasing. This prevalence can be controlled by giving proper treatment and surgery. As the number of cardiovascular surgeries increases, the demand of vascular patches for the closures will increase, thereby bolstering the market of vascular patches in North America.

Furthermore, unhealthy life is contributing for an increase in the prevalence of cardiovascular disease. Adults who eat a healthy diet live longer, have a lower risk of obesity and of heart disease. Most Americans, however, do not follow a healthy lifestyle. As per Centres for Disease Control and Prevention, 2022, fewer than 1 in 10 adults and adolescents eat enough fruits and vegetables, and 9 in 10 Americans aged 20 years or older consume more than the recommended amount of sodium. High sodium consumption can raise blood pressure, and high blood pressure is a major risk factor for heart disease and stroke. CDC also concluded the relation between unhealthy lifestyle and obesity.

Moreover, according to CDC 2022, in the United States, in 2019-2020 an estimation of 19% of young people aged 2 to 19 years and 40% of adults were suffering from obesity, which can put them at the risk for heart disease. From the above data it can be concluded that unhealthy lifestyle and obesity is one of the major cause for causing the cardiovascular diseases. This will increase the prevalence of cardiovascular disease in the forecast period owing to an increase in the demand of vascular patches in the North America market.

Furthermore, in January 2022, Centers for Disease Control and Prevention (CDC) and the Centers for Medicare & Medicaid Services (CMS) started a national initiative Million Hearts. Million Hearts exists for the sole purpose of saving more of the lives taken and protecting more of the lives impacted by heart disease and stroke in the United States. The aim of the imitation is to optimize the possibility of preventing one million preventable CVD events in the next five years. They will work by decreasing the tobacco use, physical inactivity, and particle pollution exposure.

Thus, all the above-mentioned factors are anticipated to propel the market for vascular patches in the North America.

Vascular Patches Market Key Players:

Some of the key market players operating in the vascular patches market include B. Braun Melsungen AG, Baxter., Getinge AB, Terumo Corporation, Edwards Lifesciences Corporation., LeMaitre, W. L. Gore & Associates, Inc., CryoLife, Inc., Aziyo, Medtrade Products Ltd, Collagen Solutions Plc, FOC Medical S.A., Obex, Anteris, Medtronic, Labcor Laboratorios, BD., Johnson & Johnson Services, Inc., Neovasc Inc., Axio Biosolutions, among others.

Recent Developmental Activities in the Vascular Patches Market:

In September 2022, Terumo Corporation announced the launch of global surgical graft study known as PANTHER, which is a prospective and retrospective study of a comprehensive range of knitted and woven surgical grafts and cardiovascular patches.

In June 2022, Axio Biosolutions announced FDA 510(k) clearance of its hemostatic product Axiostat Patch, which helps control moderate to severe bleeding in vascular procedures.

In October 2019, LeMaitre Vascular, Inc. announced that it has acquired the biologic patch business of Admedus Ltd for $15.5 million.

Key Takeaways from the Vascular Patches Market Report Study

  • Market size analysis for current vascular patches market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the vascular patches market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the global vascular patches market.
  • Various opportunities available for the other competitor in the vascular patches market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030.
  • Which is the top-performing regions and countries in the current vascular patches market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for vascular patches market growth in the coming future?

Target Audience who can be benefited from this Vascular Patches Market Report Study

  • Vascular patches products providers
  • Research organizations and consulting companies
  • Vascular patches-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in vascular patches
  • Various End-users who want to know more about the vascular patches market and latest technological developments in the vascular patches market.

Frequently Asked Questions for Vascular Patches Market:

1. What are vascular patches?

Vascular patches, are the patches that are broadly used in blood vessel repair and reconstruction and when blood vessels are severely compromised in cardiovascular diseases, infection, and/or in transplantation. Patches are is characterized by an excellent biocompatibility and proven long-term mechanical stability.

2. What is the market for Global vascular patches?

Global vascular patches market is estimated to grow at a CAGR of 7.37% during the forecast period from 2024 to 2030.

3. What are the drivers for the Global vascular patches market?

The vascular patches market is witnessing a positive market growth owing to the increase prevalence of cardiovascular diseases due to genetic factor, age, obesity, and unhealthy and sedentary lifestyles, bad eating habits and increasing number of geriatric patients prone to vascular disease, increasing use of vascular patches in surgeries, increased demand of minimally invasive surgeries (MIS), and technological advancements like vascular cell regeneration, cellular integration, and tissue remodelling across the world are anticipated to bolster the market.

4. Who are the key players operating in the Global vascular patches market?

Some of the key market players operating in the vascular patches market include B. Braun Melsungen AG, Baxter., Getinge AB, Terumo Corporation, Edwards Lifesciences Corporation., LeMaitre, W. L. Gore & Associates, Inc., CryoLife, Inc., Aziyo, Medtrade Products Ltd, Collagen Solutions Plc, FOC Medical S.A., Obex, Anteris, Medtronic, Labcor Laboratorios, BD., Johnson & Johnson Services, Inc., Neovasc Inc, Axio Biosolutions, and, others.

5. Which region has the highest share in vascular patches market?

North America is expected to hold the highest share in the revenue in the Vascular patches market during the forecast period. Rise in prevalence of cardiovascular diseases such as ischemic heart diseases and stroke due to unhealthy lifestyles and bad eating habits and increasing number of geriatric population prone to vascular disease will increase the demand for vascular patches in North America, leading to a rise in the overall vascular patches market growth in this region.

Table of Contents

1.Vascular patches Market Report Introduction

2.Vascular patches Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Vascular patches Market Key Factors Analysis

  • 4.1. Vascular patches Market Drivers
    • 4.1.1. Rise in prevalence of cardiovascular diseases
    • 4.1.2. Increasing number of geriatric population prone to vascular disease
    • 4.1.3. Increased use of vascular patches in surgeries and increased demand of minimally invasive surgeries (MIS)
    • 4.1.4. Technological advancements like vascular cell regeneration, cellular integration, and tissue remodeling
  • 4.2. Vascular patches Market Restraints and Challenges
    • 4.2.1. Product failure/ recalls
    • 4.2.2. Limited number of carotid endarterectomy surgeries
  • 4.3. Vascular patches Market Opportunities
    • 4.3.1. Rising demand disposable vascular patches

5. Vascular patches Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Vascular patches Market

7. Vascular patches Market Layout

  • 7.1. By Material Type
    • 7.1.1. Biologic vascular patches
    • 7.1.2. Synthetic vascular patches
  • 7.2. By Application Type
    • 7.2.1. Carotid Endarterectomy
    • 7.2.2. Aortic Aneurysms
    • 7.2.3. Profundaplasty
    • 7.2.4. Other
  • 7.3. By End User
    • 7.3.1. Hospital
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States
      • 7.4.1.2. Canada
      • 7.4.1.3. Mexico
    • 7.4.2. Europe
      • 7.4.2.1. France
      • 7.4.2.2. Germany
      • 7.4.2.3. United Kingdom
      • 7.4.2.4. Italy
      • 7.4.2.5. Spain
      • 7.4.2.6. Russia
      • 7.4.2.7. Rest of Europe
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China
      • 7.4.3.2. Japan
      • 7.4.3.3. India
      • 7.4.3.4. Australia
      • 7.4.3.5. South Korea
      • 7.4.3.6. Rest of Asia Pacific
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East
      • 7.4.4.2. Africa
      • 7.4.4.3. South America

8. Vascular patches Market Global Company Share Analysis - Key 3-5 Companies

9. Vascular patches Market Company and Product Profiles

  • 9.1. B. Braun Melsungen AG
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Baxter.
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Getinge AB
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Terumo Corporation
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Edwards Lifesciences Corporation.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. LeMaitre
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. W. L. Gore & Associates, Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. CryoLife, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Aziyo
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Medtrade Products Ltd
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Collagen Solutions Plc
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. FOC Medical S.A.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Obex
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Anteris
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Medtronic
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Labcor Laboratorios
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. BD.
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. Johnson & Johnson Services, Inc.
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Neovasc Inc.
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. Axio Biosolutions
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us